Fresenius Kabi Raises 2015 Earnings Guidance

Why to keep an eye on pharmaceuticals in NAFTA talks

Canada's trade negotiators reportedly pushed back on a single bullet point about the new trade deal between the U.S. and Mexico that a health policy expert says could boost prescription drug prices for Canadian patients.



Post a Comment

Facebook
Blogger
Disqus
Spot.IM

MKRdezign

Contact Form

Name

Email *

Message *

Powered by Blogger.
Javascript DisablePlease Enable Javascript To See All Widget